Lowe’s On Right Track With Its Long-Terms Goals In Place, Says Analyst
Telsey Advisory Group analyst Joseph Feldman reiterates an Outperform rating on the shares of Lowe’s Companies Inc (NYSE:LOW) and lowered the price target…
DigitalOcean’s 30%-Plus Revenue Growth & 20% FCF Margin Attainable In CY24, Analyst Says
Needham analyst Mike Cikos initiates coverage on DigitalOcean Holdings Inc (NYSE:DOCN) with a Buy rating and a price target of $36. Cikos…
Credit Suisse Thinks Campbell Soup’s FY23 Guidance As Too Conservative, Bumps Up Price Target By 4%
Credit Suisse analyst Robert Moskow reiterated a Neutral rating on the shares of Campbell Soup Company (NYSE:CPB) and raised the price target…
Hershey Earnings Beat Could Make For A Sweet Holiday Season, Analyst Says
In November, The Hershey Co (NYSE: HSY) had raised its full-year net sales, citing strong demand into the Christmas season.
Analyst Ming-Chi Kuo Tweets ‘My latest survey indicates Twitter cut server orders by 80% after Elon Musk’s takeover. Almost all Twitter servers use Intel chips, so this cut hurts Intel’s 2023 revenue & profits…’
https://twitter.com/mingchikuo/status/1600889062025351169
Why This Shopify Analyst Says It’s Time To Sell The E-Commerce Stock
In October, Shopify Inc (NYSE: SHOP) reported an earnings beat for the third quarter.
Yet there is near-term risk to the company’s revenues and long-term risk to its profitability, according to UBS.
Apple Car Can Single-Handedly Solve Growth Challenges And Make Up For 25% Of Tech Giant’s Business, Says Munster
The launch of the Apple Inc.’s (NASDAQ: AAPL) self-driving car could be delayed yet again, according to a Bloomberg report on Tuesday.
Elon Musk Has Picked Tesla China Exec To Be His Successor? What Top Analysts Have To Say
Tech-focused Chinese news outlet PingWest reported that Elon Musk will likely announce Tesla Inc.'s (NASDAQ:
Cramer Urges Investors To Not Panic Over Bank CEOs Saying ‘Terrifying’ Things: ‘They Don’t Know…’
Prominent market commentator Jim Cramer has cautioned investors not to panic on hearing the gloomy economic commentary from bank executives,
Bio Rad Has Almost 40% Upside On Revenue Acceleration And Margin Improvement, Analyst Says
RBC Capital Markets initiated coverage on Bio-Rad Laboratories Inc (NYSE:BIO) with an Outperform rating and a $565 price target. The analyst writes…